Aligning with earlier work, we showed that variants within the IL1RN gene that increase IL1RA are positively associated with total cholesterol, low density lipoprotein cholesterol, and glucose, but negatively with CRP concentrations,36 which adds support for IL1RA as a therapeutic target in coronary artery disease. This evidence concerns the gene IL1RN and coronary artery disorder.